Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients

Clinical Endocrinology

Volumn 75, Issue 4, 2011, Pages 505-513

  Behan, Lucy Ann ^a   Rogers, Bairbre ^a   Hannon, Mark J ^a   O'Kelly, Patrick ^a   Tormey, William ^a   Smith, Diarmuid ^a   Thompson, Christopher J ^a   Agha, Amar ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GONADOTROPIN; HYDROCORTISONE; PROLACTIN; TESTOSTERONE; THYROTROPIN; THYROXINE; TRANSCORTIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN DEFICIENCY; CROSSOVER PROCEDURE; DRUG DOSE COMPARISON; ENERGY; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPITUITARISM; MALE; MORNING DOSAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; MALE; MIDDLE AGED;

EID: 80052553187     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04074.x     Document Type: Article

References (43)

1. Stockholm, K., Gravholt, C.H., Laursen, T., et al. (2007) Mortality and GH deficiency: a nationwide study. European Journal of Endocrinology, 157, 9-18. (Pubitemid 47162560)
2. Nielsen, E.H., Lindholm, J., &, Laurberg, P., (2007) Excess mortality in women with pituitary disease: meta-analysis. Clinical Endocrinology (Oxf), 67, 693-697. (Pubitemid 47620433)
3. Santos, A., Resmini, E., Martinez, M.A., et al. (2009) Quality of life in patients with pituitary tumors. Current Opinion in Endocrinology, Diabetes and Obesity, 16, 299-303.
4. Bulow, B., Hagmar, L., Mickoczy, Z., et al. (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology (Oxf), 46, 75-81. (Pubitemid 27072849)
5. Rosen, T., &, Bengtsson, B.A., (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285-288. (Pubitemid 20229130)
6. Tomlinson, J.W., Holden, N., Hills, R.K., et al. (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet, 357, 425-431.
7. Filipsson, H., Monson, J.P., Koltowska-Haggstrom, M., et al. (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and co-morbidity in hypopituitary patients. Journal of Clinical Endocrinology and Metabolism, 91, 3954-3961. (Pubitemid 44536870)
8. Sherlock, M., Reulen, R.C., Aragon Alonso, A., et al. (2009) ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 94, 4216-4223.
9. Monson, J.P., (1997) The assessment of glucocorticoid replacement therapy. Clinical Endocrinology (Oxf), 46, 269-270. (Pubitemid 27174328)
10. Agha, A., Liew, A., Finucane, F., et al. (2004) Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency. Clinical Endocrinology (Oxf), 60, 688-693. (Pubitemid 38788075)
11. Besser, G.M., &, Jeffcoate, W.J., (1976) Adrenal disease. British Medical Journal, 1, 448-451.
12. Arlt, W., Rosenthal, C., Hahnert, S., et al. (2006) Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clinical Endocrinology (Oxf), 64, 384-389.
13. Arlt, W., (2009) The approach to the adult with newly diagnosed adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism, 94, 1059-1067.
14. Perogamvros, I., Aarons, L., Miller, A.G., et al. (2011) Corticosteroid-binding globulin regulates cortisol pharmacokinetics. Clinical Endocrinology, 74, 30-36.
15. Brazier, J.E., Harper, R., Jones, N.M., et al. (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. British Medical Journal, 305, 160-164.
16. Hunt, S.M., McKenna, S.P., McEwan, J., et al. (1980) A quantitative approach to perceived health status: a validation study. Journal of Epidemiology and Community Health, 34, 281-286. (Pubitemid 11207401)
17. Coolens, J.L., van Baelen, H., &, Heyns, W., (1987) Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. Journal of Steroid Biochemistry, 26, 197-202. (Pubitemid 17040122)
18. Estaban, N.V., Loughlin, T., Yergey, A.L., et al. (1991) Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 72, 39-45. (Pubitemid 21921653)
19. Kerrigan, J.R., Veldhuis, J.D., Leyo, S.A., et al. (1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. Journal of Clinical Endocrinology and Metabolism, 76, 1505-1510. (Pubitemid 23164369)
20. Peacey, S.R., Guo, C.Y., Robinson, A.M., et al. (1997) Glucocorticoid replacement therapy: are patients over treated and does it matter? Clinical Endocrinology, 46, 255-261. (Pubitemid 27174326)
21. Ten, S., New, M., &, McLaren, M., (2001) Clinical Review 130: Addison's disease. Journal of Clinical Endocrinology and Metabolism, 86, 2909-2922. (Pubitemid 32673441)
22. Darzy, K.H., &, Shalet, S.M., (2005) Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumours. The Journal of Clinical Endocrinology and Metabolism, 90, 5217-5225. (Pubitemid 41262277)
23. Debono, M., Ghobadia, C., Rostami-Hodjegan, A., et al. (2009) Modified-release hydrocortisone to provide circadian cortisol profiles. Journal of Clinical Endocrinology and Metabolism, 94, 1548-1554.
24. Merza, Z., Rostami-Hodjegan, A., Memmott, A., et al. (2006) Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clinical Endocrinology (Oxf), 65, 45-50.
25. Druce, M.R., Akker, S.A., Chew, S.L., et al. (2010) Morbidity in patients on long-term steroid replacement therapy. Clinical Endocrinology, 72, 564-566.
26. Grossman, A.B., (2010) The diagnosis and management of central hypoadrenalism. Journal of Clinical Endocrinology and Metabolism, 95, 4855-4863.
27. Groves, R.W., Toms, G.C., Houghton, B.J., et al. (1988) Corticosteroid replacement therapy: twice or thrice daily? Journal of the Royal Society of Medicine, 81, 514-516.
28. Howlett, T.A., (1997) An assessment of optimal hydrocortisone replacement therapy. Clinical Endocrinology, 46, 263-268. (Pubitemid 27174327)
29. Mah, P.M., Jenkins, R.C., Rostami-Hodjegan, A., et al. (2004) Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clinical Endocrinology, 61, 367-375. (Pubitemid 39287067)
30. Jansson, J.O., Oscarsson, J., Mode, A., et al. (1989) Plasma growth hormone pattern and androgens influence the levels of corticosteroid-binding globulin in rat serum. Journal of Endocrinology, 122, 725-732. (Pubitemid 19220630)
31. Breuner, C.W., &, Orchinik, M., (2002) Plasma binding proteins as mediators of corticosteroid action in vertebrates. Journal of Endocrinology, 175, 99-112. (Pubitemid 35276590)
32. le Roux, C.W., Sivakumaran, S., Alaghband-Zadeh, J., et al. (2002) Free cortisol index as a surrogate marker for serum free cortisol. Annals of Clinical Biochemistry, 39, 406-408. (Pubitemid 34743644)
33. Levine, A., Zagoory-Sharon, O., Feldman, R., et al. (2007) Measuring cortisol in human psychobiological studies. Physiology and Behaviour, 90, 43-53. (Pubitemid 44918006)
34. Kerlik, J., Penesova, A., Vleck, M., et al. (2010) Comparison of salivary cortisol and calculated free plasma cortisol during low-dose ACTH test in healthy subjects. Clinical Biochemistry, 43, 764-767.
35. Barlow, N.L., Holme, J., Stockley, R.A., et al. (2010) An evaluation of measured and calculated free serum cortisol in a group of patients with known adrenal suppression. Annals of Clinical Biochemistry, 47, 200-204.
36. Ho, J.T., Al-Musalhi, H., Chapman, M.J., et al. (2006) septic shock and sepsis: a comparison of total and free plasma cortisol levels. Journal of Clinical Endocrinology and Metabolism, 91, 105-114. (Pubitemid 43069125)
37. Brien, T.G., (1981) Human corticosteroid-binding globulin. Clinical Endocrinology, 14, 193-212.
38. Heald, A.H., Ghosh, S., Bray, S., et al. (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing's disease. Clinical Endocrinology (Oxf), 61, 458-465. (Pubitemid 39388484)
39. Kauppinen-Makelin, R., Sane, T., Sintonen, H., et al. (2006) Quality of life in treated patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 91, 3891-3896. (Pubitemid 44536860)
40. Nielsen, E.H., Lindholm, J., Laurberg, P., et al. (2007) Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function. Pituitary, 10, 67-73. (Pubitemid 46566176)
41. van der Klaauw, A.A., Kars, M., Biermasz, N.R., et al. (2008) Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clinical Endocrinology (Oxf), 69, 775-784.
42. Dekkers, O.M., van der Klaauw, A.A., Pereira, A.M., et al. (2006) Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. Journal of Clinical Endocrinology and Metabolism, 91, 3364-3369. (Pubitemid 44402105)
43. Danilowicz, K., Bruno, O.D., Manavela, M., et al. (2008) Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary, 11, 279-285.